phosphorylation, a marker of VASP activation, were dramatically reduced in aortic tissue of mice with obesity induced by consuming a HFD. As reported previously, the effect of the HFD was associated with increased aortic inflammation, as measured by increased NF-Bdependent gene expression, and reduced vascular insulin sensitivity (including insulin-stimulated phosphorylation of eNOS and Akt). These effects of the HFD were recapitulated by VASP knockout, implying a physiological role for VASP to constrain inflammatory signaling and thereby maintain vascular insulin sensitivity. Conversely, overexpression of VASP in endothelial cells blocked inflammation and insulin resistance induced by palmitate. The finding that transplantation of bone marrow from VASP-deficient donors into normal recipients does not recapitulate the vascular effects of whole body VASP deficiency suggests that the protective effects of this enzyme are not mediated in immune or other bone marrow-derived cells. These studies implicate VASP as a downstream mediator of the NO/cGMP pathway that is both necessary and sufficient to protect against vascular inflammation and insulin resistance. As such, this work identifies VASP as a potential therapeutic target in the treatment of obesity-related vascular dysfunction. vascular inflammation; vasodilatory-stimulated phosphoprotein; nitric oxide TYPE 2 DIABETES, OBESITY, AND OTHER CONDITIONS of nutrient excess are associated with a heightened inflammatory milieu in many tissues, including the vasculature (10, 21) . During highfat diet (HFD) feeding, inflammation develops within mouse vasculature within 1 wk, well before it appears in classical insulin-sensitive tissues such as muscle, liver, or fat (12) . Elevated concentrations of saturated free fatty acids (FFA) within the vasculature have been implicated in the mechanism whereby nutrient excess activates IKK␤ and subsequently the nuclear factor NF-B, a key transcriptional mediator of inflammation (3, 11, 25) . Activation of this inflammatory pathway is associated with reduced endothelial nitric oxide (NO) production, which in turn is implicated in the induction of vascular insulin resistance (23) in obesity-induced animal models (14) . Thus, attenuation of vascular inflammation has the potential to delay the onset of vascular insulin resistance. Consistent with this hypothesis, reduced NO increases endothelial susceptibility to the inflammatory effects of saturated FFAs (such as palmitate), and reduced vascular NO content precedes the onset of vascular inflammation and insulin resistance during HFD feeding (12) .
Several observations indicate that endothelial NO plays a physiological role to protect against vascular inflammation. For one, restoration of normal NO levels through either genetic or pharmacological means attenuates palmitate-induced vascular inflammation and insulin resistance, whereas experimental deficiency of endothelial nitric oxide synthetase (eNOS) has the opposite effect (23) . These anti-inflammatory effects of NO occur at low concentrations and are to be distinguished from the potent proinflammatory cytotoxic effects of much higher levels of NO released by macrophages following activation of inducible nitric oxide synthetase. In this study, we sought to identify intracellular mediators downstream of endothelial NO signaling that are responsible for its anti-inflammatory vascular effect.
Endothelial NO signaling involves activation of soluble guanylate cyclase, which catalyzes synthesis of cGMP, which in turn activates 3=,5=-cyclic monophosphate (cGMP)-dependent protein kinase (PKG). Among the downstream targets of PKG is the enzyme vasodilatory-stimulated phosphoprotein (VASP), originally identified in platelets (9) . VASP family members have subsequently emerged as important regulators of actin assembly and cell migration, but whether VASP participates in the anti-inflammatory effects of vascular NO signaling is unknown (4) . PKG preferentially phosphorylates VASP at Ser 239 , and in rodent models of diabetes, actin cytoskeleton rearrangements in vascular tissue have been attributed to reductions of both PKG and VASP signaling (24) . Although VASP was recently reported to exert anti-inflammatory effects in both adipose tissue and liver (7, 26) , whether it mediates similar effects within the vasculature is an important unanswered question.
MATERIALS AND METHODS

Materials
Anti-VASP, anti-phospo-VASP (Ser 239 ), anti-PKG, anti-phosphop65, and phoshoprylated eNOS (p-eNOS) antibodies were obtained from Cell Signaling Technology (Beverly, MA). Total Akt and p-Akt (Ser 473 ) ELISA kits were obtained from Biosource (Camarillo, CA) and p-eNOS (Ser 1177 ) ELISA kits from Cell Signaling Technology. IL-6, intracellular adhesion molecule-1 (ICAM-1), VCAM-1, and suppressor of cytokine signaling 3 mRNA expression levels were measured using TaqMan gene expression assays (Applied Biosys- 
Cell Culture
Human microvascular endothelial cells (HMEC) and bovine aortic endothelial cells (BAEC) (Invitrogen-Cascade Biological, Carlsbad, CA) were cultured in RPMI 1640 supplemented with 10% fetal bovine serum (Hyclone Laboratories, Logan, UT) and 12 g/ml of bovine brain extract (Clonetics, Walkersville, MD), L-glutamine (2 mM), sodium pyruvate (1 mM), and nonessential amino acids in the presence of penicillin (100 U/ml) and maintained at 37°C in 5% CO 2. All Western blots were performed as described (6) , with equal amounts of total protein for each condition and experiment used. SDS gel electrophoresis was performed using a 4 ϫ 20% gradient gel. A retroviral construct containing human wild-type VASP in the retroviral vector LXSN was used for overexpression studies. HMEC or BAEC cells were infected with the LXSN or LXSN-wt-VASP virus (4) . Multiple clones were selected, propagated, and maintained in the presence of G418 (0.6 mg/ml; Cellgro, Manassas, VA).
NO Measurement
NO was measured using the spin trap Fe(DETC) 2, which was first reported and validated by Kleschyov et al. (16) .
Preparation of Colloid Fe(DETC) 2
Sodium DETC (3.6 mg) and FeSO4 7 H20 (2.25 mg) were dissolved under argon gas in 10 ml of ice-cold Krebs-Hepes buffer (1) [consisting of (in mM) 99 NaCl, 4.7 KCl, 1.2 MgSO 4, 1.0 KH2PO4, 1.9 CaCl2, 25 NaHCO3, 11.1 glucose, and 20 Na-HEPES, pH 7.4]. These were rapidly mixed to obtain a pale yellow/brown-colored Fe(DETC)2 solution that was used immediately. Thoracic aortas were cleaned of adhering fat and soft tissue and kept in ice-cold Krebs solution, and aortic samples were sectioned and separated into six-well plates each containing 100 l of Krebs-HEPES buffer. Colloid Fe(DETC) 2 was then added to final concentration of 286 M and incubated at 37°C for 90 min.
Electron spin resonance (ESR) spectroscopy studies were performed on a tabletop x-band spectrometer (Miniscope; Magnettech). Recordings were made at 77 K using a Dewar flask. Instrument settings were 10 mW of microwave power, 1 mT of amplitude modulation, 100 kHz of modulation frequency, 20 s of sweep time, and 10 scans.
Quantitative RT-PCR Analyses
RNA was extracted using the RNAase kit (Quiagen, Hilden, Germany). For gene expression analysis, real-time RT-PCR reactions were conducted as described previously (12) using TaqMan Gene Expression Analysis (Applied Biosystems, Grand Island, NY).
Study Protocol
Adult male C57BL/6 and littermate Vasp Ϫ/Ϫ mice were maintained in a temperature-controlled facility with a 12-h light-dark cycle. Age-matched groups (6 -12 wk of age; n ϭ 6 -14/group) were fed an equicaloric diet that was either low (10% saturated fat) or high in fat content (60% saturated fat) (nos. D12492 and D12450B; Research Diets, New Brunswick, NJ) for period of 2-4 wk. Body weight and food intake were measured weekly.
Adult male db/db and control mice (db/ϩm) and eNos Ϫ/Ϫ mice were purchased from The Jackson Laboratory and fed standard chow. For studies using the phosphodieserase-5 inhibitor sildenafil, sildenafil tablets (100 mg; Pfizer, New York, NY) were ground into a powder and mixed into a highly palatable "treat" (300 mg) containing peanut butter and a high-fat food pellet (Research Diets) so as to deliver sildenafil orally at a dose of 10 mg·kg Ϫ1 ·day Ϫ1 . Vehicle-treated controls received the same daily treat without sildenafil, which was reliably and rapidly consumed. Sildenafil or vehicle was given once daily for the final 2 wk of an 8-wk study protocol in which mice were fed either the HFD or LFD.
At the conclusion of the dietary intervention, one-half of the animals in each study group received an intraperitoneal injection of either vehicle (normal saline) or regular insulin (0.06 U/g body wt in 200 l of normal saline) after an overnight fast. Fifteen minutes later, mice were euthanized with an overdose of CO 2, followed by cervical dislocation. Thoracic aortae were removed and snap-frozen on dry ice after the surrounding connective tissue was dissected away. Protein was subsequently extracted from tissue samples, and after protein levels were quantified (Micro BCA Protein Assay Kit; Pierce, Rockford, IL), equal amounts of protein were used for each condition in each assay. Total Akt and phospho-Akt (Ser 473 ) levels were determined using ELISA assay kits (Biosource). In parallel studies after mice were euthanized, thoracic aorta were removed and placed into RNA Later (Ambion, Austin, TX) and subsequently processed to obtain total RNA. All study protocols were approved by the University of Washington Institutional Animal Care and Use Committee.
Bone Marrow Transplant Protocol
Control bone marrow transplant experiment 1. To control for potentially confounding effects of the transplant procedure, male WT mice (C57Bl6) aged 6 -8 wk were lethally irradiated and transplanted with marrow from male WT mice (WT/WT) mice. Similarly, Vasp Ϫ/Ϫ mice aged 6 -8 wk were lethally irradiated and transplanted with marrow from Vasp Ϫ/Ϫ mice (KO/KO) mice. Bone marrow transplant experiment 2. To investigate whether VASP signaling in bone marrow-derived cells is necessary for its anti-inflammatory effects in aortic tissue, male WT mice aged 6 -8 wk received marrow from Vasp Ϫ/Ϫ mice (KO/WT) following lethal irradiation. To determine whether normal bone marrow-derived cells are sufficient to reverse the vascular inflammation observed in mice lacking VASP, male Vasp Ϫ/Ϫ mice aged 6 -8 wk were transplanted with marrow from WT mice (WT/KO) following lethal irradiation. Treated mice were allowed to recover for 4 wk on a standard chow diet, after which they were switched to a LFD at the beginning of the study.
Statistical Analysis
For all comparisons of data obtained using Western blot analysis, densitometry measurements were normalized to control values obtained from samples incubated with vehicle alone, and percent change relative to the control condition was calculated. Analysis of the results was performed using the STATA8 statistical package. Data are expressed as means Ϯ SE, and values of P Ͻ 0.05 were considered statistically significant. A two-tailed t-test was used to compare mean values from studies involving two experimental groups. To compare responses following treatment with vehicle or insulin across the two diets, data were analyzed by two-way analysis of variance, followed by the Bonferoni post hoc comparison test.
RESULTS
Effect of HF Feeding on Vascular VASP and PKG
To investigate the hypothesis that reduced aortic NO signaling is associated with decreased VASP phosphorylation in vivo, we employed a mouse model of diet-induced obesity (DIO) induced by consuming a HFD for 4 wk, which was shown previously to reduce vascular NO levels and induce vascular inflammation and insulin resistance (12) . Whole cell aortic lysates were collected, and Western blot analysis was used to examine total VASP levels, VASP phosphorylation at Ser 239 (p239-VASP, an indicator of VASP activity), and total PKG protein. As expected, p239-VASP levels were reduced in aortic tissue from the DIO group compared with LFD-fed controls, whereas no significant differences were seen in vascular PKG levels ( Fig. 1, A and B) . This outcome was accompanied by the expected increase in aortic NF-B signaling (12) , as assessed by phopsho-p65 levels, in the DIO group (Fig. 1C) .
Relationship Between NO Levels and Vasp 239 phosphorylation
As a further test of the hypothesis that reduced vascular NO levels are coupled to reduced VASP phosphorylation, we studied both genetically obese diabetic db/db mice and mice lacking eNOS (eNos Ϫ/Ϫ ). As expected, aortic NO levels [measured by ESR using the NO spin trap Fe(DETC) 2 ] were reduced in both mouse models ( Fig. 2A) . Similarly, thoracic aortic content of p239-VASP was markedly reduced (Fig. 2B ) in both db/db and eNos Ϫ/Ϫ mice compared with WT controls. In contrast, basal thoracic NO levels were normal in Vasp Ϫ/Ϫ mice, suggesting that the absence of VASP does not alter thoracic aortic NO levels (Fig. 2C) . Collectively, these observations support the conclusion that a reduction of vascular NO levels leads to reduced p239-VASP content, as predicted given that VASP phosphorylation lies downstream of NO signaling.
Effect of Increased cGMP Signaling on VASP Ser 239 Phosphorylation
To determine whether increased NO/cGMP signaling increases VASP Ser 239 phosphorylation, HMECs were incubated with either the NO donor DETA-NO (50 M for 12 h) or the cGMP analog 8-Br-cGMP (50 M for 12 h). As expected, endothelial content of p239-VASP was increased in HMECs in response to each intervention (Fig. 3A) . To investigate this question in vivo, we administered either vehicle or the PDE5 inhibitor sildenafil, which increases cGMP levels by reducing its degradation, to normal mice fed either a LFD or HFD diet for 8 wk. p239-VASP levels were then assessed in lysates of thoracic aorta from each group. Among HFD-fed mice, sildenafil treatment increased p239-VASP levels, whereas VASP phosphorylation was reduced in mice receiving vehicle treatment (Fig. 3B) .
Effect of VASP dDficiency on Vascular Inflammation and Insulin Signaling In Vivo
Based on our finding that reduced NO signaling lowers p239-VASP levels in aortic tissue ( Fig. 1 ) and previous evidence that reduced vascular NO levels increase susceptibility to the inflammatory effects of HFD-feeding (23), we next asked whether whole body VASP deficiency predisposes to vascular inflammation and insulin resistance. Effect of high-fat (HF) diet feeding on phosphorylation of vasodilatory-stimulated phosphoprotein (VASP) and vascular inflammation in aortic tissue. C57BL/6 mice were fed a HF (60% saturated fat) or a low-fat (LF; 10% saturated fat) diet for 8 wk. Lysates of aortic tissue from LF-and HF-fed mice were analyzed by Western blots to detect total 3=,5=-cyclic monophosphate (cGMP)-dependent protein kinase (PKG) and phosphorylation of VASP at Ser 239 . A: PKG normalized to GAPDH; representative blot is shown for n ϭ 3, with quantification completed on n ϭ 6. B: relative phosphorylation of VASP at Ser 239 normalized to VASP. *P Ͻ 0.05 LF vs. HF; n ϭ 6. C: as seen previously (12), HF feeding increased aortic tissue inflammation as assessed by phospho-p65 (n ϭ 5). did not differ from WT controls with respect to body weight, body composition, or aortic NO content after 4 wk on the control (LFD) diet (Fig. 4A ). Prior to study termination, mice in each group received either vehicle or insulin (0.6 U/g body wt ip), and 15 min later mice were euthanized, and the thoracic aorta was harvested and snap-frozen for subsequent measurement of insulin signaling.
We found that, relative to littermate controls, mice lacking VASP exhibited both increased vascular inflammation (Fig.  4B ) and reduced insulin-mediated phosphorylation of Akt and eNOS (measures of insulin signaling) in aortic tissue (Fig. 4C) . This observation suggests that VASP plays a physiological role to protect against vascular inflammation and insulin resistance.
As such, VASP is implicated as a key mediator of the protective vascular effects conferred by the NO/cGMP pathway.
Contribution of VASP Deficiency from Bone MarrowDerived Cells
Because macrophages are implicated in the pathogenesis of both atherogenesis and associated vascular inflammation (18), we hypothesized that the protective role of VASP with respect to vascular inflammation involves an action in macrophages, monocytes, or other cells of bone marrow origin. To test this hypothesis, we sought to determine whether 1) deficiency of VASP specifically from marrow-derived cells is sufficient to Phospho-p65 expression levels were analyzed by Western blot of aortic tissue extracts to assess activation of NF-B. All protein levels were normalized to GAPDH. C: LFfed WT and Vasp Ϫ/Ϫ mice were administered vehicle (con) or insulin (ins; 0.6 U/g body wt ip) to measure biochemical insulin sensitivity. Levels of p-Akt and phosphorylated eNOS (p-eNOS) within aortic tissues were measured by ELISA. *P Ͻ 0. 05 (Fig. 5A ).
As expected, VASP expression was reduced in bone marrow-derived macrophages harvested from WT mice following transplant of VASP-deficient bone marrow (KO/WT), whereas vascular content of VASP was normal in these mice. Thus, macrophages do not appear to be a major source of VASP in the thoracic aorta. Following a 4-wk recovery from the bone marrow transplant procedure (during which all mice were fed a standard chow diet), the four groups were placed on the LFD for a subsequent 4-wk period. No significant differences in body weight were noted between the four groups (data not shown). Consistent with our earlier results (Fig. 4A) , the KO/KO group demonstrated evidence of increased vascular NF-kB activation compared with the WT/WT group (Fig. 5B) . Whereas mice lacking VASP only in marrow-derived cells (KO/WT) did not exhibit increased NF-B activation, this inflammatory activation was evident in mice in which bone marrow-derived cells are the only cells that express VASP (WT/KO) (Fig. 5B) . These findings suggest that the protective role played by VASP with respect to vascular inflammation is not contained within macrophages or other cells of bone marrow lineage.
To assess vascular insulin sensitivity, insulin-mediated activation of Akt and eNOS signaling was assessed in the same thoracic aortic lysates. As expected, vascular insulin signaling was intact in both the WT/WT and KO/WT mice, whereas it was reduced in both the KO/KO and WT/KO groups ( insulin resistance and inflammatory response characteristic of the vasculature of mice lacking VASP and 2) VASP deficiency in immune cells does not trigger vascular inflammation or insulin resistance in mice with intact VASP signaling elsewhere in the body. Although additional studies are needed, these observations suggest that the protective, anti-inflammatory effect of VASP in the vasculature is mediated by endothelial cells or other vascular cell types rather than by macrophages or other marrow-derived cells.
Effect of VASP Overexpression in HMEC on Endothelial Inflammation and Insulin Signaling
Based on these observations, we hypothesized that increased VASP signaling would attenuate endothelial NF-B signaling in response to nutrient excess. To test this hypothesis, we used retroviral vectors to overexpress constructs containing either WT VASP or a reporter gene (GFP) in HMEC. Expression was confirmed by Western blot using an anti-VASP antibody (Fig. 6A) . Palmitate reduced p239-VASP levels in GFP-transduced endothelial cells; however, in WT VASP-transduced cells, palmitate did not alter p239-VASP levels (Fig. 6B) . As expected, exposure of control (GFP-transduced) endothelial cells to palmitate resulted in robust inflammatory signaling measured as increases of ICAM and IL-6 gene expression, and this effect was blocked by overexpression of WT VASP (Fig.  6, C and D) . To determine whether changes in basal NO content influence the anti-inflammatory effects of VASP overexpression, we pretreated transduced HMEC with the eNOS inhibitor N G -nitro-L-arginine methyl ester (50 M). In WTtransduced HMEC, eNOS inhibition potentiated palmitatemediated NF-B activation, a finding seen previously (Fig. 6,  C and D) (23) . However, the presence of eNOS inhibition did not significantly alter the anti-inflammatory effect induced by overexpression of WT VASP. Similarly, palmitate-induced insulin resistance (reduced insulin-mediated phosphorylation of Akt and eNOS) observed in control HMEC was blocked by overexpression of WT VASP (Fig. 6, E and F) . To confirm these findings, the study was replicated in BAEC (data not shown), demonstrating that similar findings are obtained whether endothelial cells are derived from large or small vessels. Together, these findings suggest that VASP acts downstream of NO signaling in endothelial cells and that increased VASP signaling is sufficient to block the inflammation and insulin resistance induced by exposure to palmitate.
DISCUSSION
Chronic low-grade inflammation in insulin-sensitive tissues, including the vasculature, is implicated in the link between obesity, insulin resistance, and diabetes (21, 27) . Reduced NO bioavailability, which occurs in mice within 1 wk of HFD feeding (12) , increases endothelial cell susceptibility to the inflammatory effects of excess nutrition. This in turn further reduces NO production, leading to a "vicious cycle" of increased vascular inflammation and reduced NO levels. Conversely, increasing downstream NO signaling in vivo during high-fat feeding reduces vascular inflammation (23), thus breaking this vicious cycle and restoring vascular insulin sensitivity. Our current findings extend this area of research by identifying a key role for VASP as a downstream mediator of NO signaling in the control of vascular inflammation. We found that in aortic tissue from mice with reduced vascular NO signaling (due to either nutrient excess or deficiency of eNOS), phosphorylation of VASP at the Ser 239 site (the preferential phosphorylation site of PKG) is also reduced. Genetic deficiency of VASP recapitulates the proinflammatory state induced in aortic tissue by NO deficiency, an effect associated with impaired insulin signaling, findings typical of mice placed on a HFD. Conversely, VASP overexpression protects cultured endothelial cells from inflammation and insulin resistance induced by palmitate. Together, these findings demonstrate that endogenous VASP signaling acts downstream of NO to protect against vascular inflammation and insulin resistance induced by nutrient excess.
The therapeutic potential of the NO signaling pathway is limited by the fact that as concentrations of NO produced by eNOS increase, peroxynitrite formation can result, increasing oxidative stress and producing a cytotoxic proinflammatory rather than an anti-inflammatory state (8) . This concern is underscored by the unexpected finding that on an apoE Ϫ/Ϫ background, the aortas of eNOS transgenic mice paradoxically exhibit higher atherosclerotic burden compared with their agematched controls, with higher reactive oxygen species levels within the aorta than controls (22) . Such results demonstrate the relatively narrow therapeutic range of NO and highlight the importance of targets downstream of NO as potential approaches to reverse obesity-associated vascular impairment. Previously, we showed that using a selective phosphodieserase-5 inhibitor to inhibit the breakdown of cGMP restores impaired insulin signaling and attenuates NF-B activation in the vasculature of DIO mice (23) . However, this pharmacological strategy upregulates all downstream targets of the NO/cGMP pathway, increasing the potential for off-target effects. On theoretical grounds, therapeutic agents that activate VASP have greater specificity and thus may have the same beneficial effects with fewer side effects. Future studies to investigate this hypothesis are warranted.
The endothelium is actually considered to be "insulin-sensitive" in that vasodilation leading to increased blood flow is a major physiological consequence of insulin-stimulated NO production (2, 28) . Therefore, a physiological consequence of vascular insulin resistance is a reduction of NO production, resulting in endothelial dysfunction, an early marker for vascular disease. Insulin-signaling pathways in vascular endothelium leading to NO production are distinct from calcium-dependent mechanisms and involve the phosphorylation of IRS-1, phosphatidylinositol 3-kinase, Akt, and ultimately eNOS Ser 1177 phosphorylation (20) . During vascular insulin resistance this insulin-signaling pathway is impaired in a similar manner as that found in liver, muscle, or adipose tissue (15) . Many laboratories have suggested that activation of NF-B pathways in the vasculature result in attenuation of the insulin-signaling pathway, and strategies to reduce vascular NF-B during vascular insulin resistance have been shown to restore insulin-mediated NO production (23) (Fig. 7) .
Although the mechanism underlying the anti-inflammatory action of VASP remains to be elucidated, our data are strongly supportive of the hypothesis that it is a downstream mediator of NO signaling. First, whereas VASP deficiency had no effect on aortic NO content (in Vasp Ϫ/Ϫ mice), aortic VASP phosphorylation is reduced in conditions associated with reduced aortic NO content (DIO, db/db mice, eNos Ϫ/Ϫ mice). Thus, phospho-VASP content tracks with changes in thoracic aortic NO content, whereas the reverse does not appear to hold. Second, the effect of reduced NO synthesis to trigger NF-B activation in endothelial cells was reversed by VASP overexpression, consistent with the hypothesis that reduced VASP signaling is required for the proinflammatory consequences of reduced endothelial NO signaling.
The protective effect of VASP on vascular inflammation mimics our recent findings that phosphorylation of VASP is required for the effect of NO-cGMP signaling to limit obesityassociated adipose tissue inflammation (7) and that VASP deficiency induces liver inflammation in association with hepatic steatosis and insulin resistance (26) phages or other marrow-derived cells, a somewhat surprising finding given the established role of macrophages in obesityassociated atherosclerosis. Moreover, our unpublished work suggests that in the liver, the anti-inflammatory actions of VASP reside within Kupffer cells, the resident macrophage of the liver. Efforts to identify specific cell types involved in the anti-inflammatory effects of NO signaling are an important priority for future work, as is investigation into the role of VASP in the pathogenesis of atherosclerosis.
That IKK␤-NF-B activation mediates palmitate-induced insulin resistance in endothelial cells was established in previous work (13) , which also showed that signaling via the innate immune receptor Toll-like receptor 4 (TLR4) is required for this effect (11) . Therefore, the mechanism underlying the anti-inflammatory action of VASP may involve antagonism of the palmitate/TLR4/IKK␤/NF-B pathway. Whether the specific mechanism involves an interaction of VASP directly with NF-B or with upstream signaling molecules is unknown, and several possibilities exist. For one, VASP regulates actin polymerization (17) , and the actin cytoskeleton may in turn regulate NF-B translocation to the nucleus in response to thrombin (5) . This model is consistent with the dynamic nature of the actin cytoskeleton and the fact that its polymerization and depolymerization are critical determinants of many cellular responses, including inflammatory activation. Alternatively, VASP may mediate its anti-inflammatory effects via the enzyme RhoA kinase (ROCK), which is normally inhibited by VASP-mediated phosphorylation. Because increases in ROCK activity are associated with increased vascular inflammation and atherosclerosis (19) , loss of VASP signaling may trigger NF-B activation via ROCK activation in endothelial cells. Additional studies are warranted to identify mechanisms underlying VASP-mediated inhibition of the endothelial response to palmitate.
In summary, we show for the first time that within the vasculature VASP plays a critical role to mediate the antiinflammatory response associated with NO/cGMP signaling and that deficiency of VASP results in vascular inflammation and insulin resistance. Because obesity is a state of chronic inflammation and VASP deficiency is associated with inflammation across multiple tissues, our results identify VASP as a novel potential target for the treatment of obesity-related cardiometabolic disease.
